Approval · Notice of Compliance 27960 · 2022
PERJETA: Notice of Compliance 27960
Issued April 7, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27960
- Date
- April 7, 2022
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New drug product manufacturing facility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PERJETA | Not yet assigned | — |
| PERJETA-HERCEPTIN COMBO PACK | Not yet assigned | — |
Medicinal ingredients
- PERTUZUMAB 420 MG per 14ML